EURO SHOCK at a glance
As the first pan-European clinical study of its kind, EURO SHOCK is testing a novel intervention procedure aimed at reducing the high mortality associated with cardiogenic shock and alleviating its burden on chronic heart failure. The core aim of EURO SHOCK is therefore to test the early use of an Extracorporeal Membrane Oxygenation Machine (ECMO) to improve the poor outcomes seen in patients with cardiogenic shock.
Testing acute early up-front use of ECMO
Investigate whether benefits outweigh risks and complication
If effective, determine which patients benefit and if benefits are cost effective